Prioritizing Mental Health, Accessibility, and Equity in RI Health Innovation

Share on Social Media

NEMIC is opening a rolling application to the NEMIC Accelerator Program The program is an intensive, 3-month, business accelerator geared towards mental health, equity, and telehealth solutions.

The COVID-19 pandemic revealed the need for effective healthcare response plans. It also highlighted the need for services for underrepresented communities and underrepresented health entrepreneurs. These communities consist of minority ethnic groups, underprivileged neighborhoods, remotely located areas where healthcare service organizations are not readily available, and more. This program will accelerate and incubate startups that have innovative solutions in this new age of healthcare.
 Accepted Startups will receive:6-20 training hoursBi-weekly advisoryUp to $10,000 in funding Access to NEMIC’s network of investors and experts NEMIC’s signature Med Tech Leadership Classes
The program serves minority populations through a two-pronged approach. First, it will seek technologies that address health equity problems. Second, it will prioritize underrepresented/minority-owned company applicants.5-10 qualified participants will develop, solidify their business model, and test their solutions.Participants will receive up to $10,000 to engage in key activities and move their startups closer to being investable. During this program, participants are required to take specified NEMIC educational Med Tech Leadership Program sessions, work towards accomplishing project milestones and meet external stakeholders to validate and collect data.
Schedule and Details:The NEMIC Accelerator Program is funded through Real Jobs RI.Applicants must be a Rhode Island resident, employed by a Rhode Island based company or organization, or a student of a RI University or Institution.  Applications are rollingApplication open until program cohort is fullProgram start date based on participant availability
REGISTER »

Latest News

College Choice ranks URI biotechnology program 4th in nation

College Choice ranks URI biotechnology program 4th in nation

KINGSTON, R.I. – January, 2019 – The University of Rhode Island’s program in biotechnology has been ranked fourth best in the nation by College Choice, an online resource for students selecting a college to attend. URI has the highest ranked biotechnology program in...

Rubius Turns Immunotherapy Red

Rubius Turns Immunotherapy Red

As it gets ready to bring the first engineered red blood cell therapy into the clinic, Rubius Therapeutics Inc. is working up the next generation of RBC therapies to mimic immune cell interactions. The company is exploiting the cells’ unique biology to expand its...

Biotech Industry News